Morio Ozawa

AbbVie GK

ADALIMUMAB ACHIEVES COMPLETE REMISSION AT 52 WEEKS IN JAPANESE PATIENTS WITH INTESTINAL BEHÇET'S DISEASE
2013-01-01
English, Medical management, Inflammatory bowel disease, Abstract, 'IBD-ology', 2013